QA: Calithera Biosciences Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001496671_2022_Calithera_Biosciences_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001496671, Calithera Biosciences Inc

  xvar xval
0 AssetsCurrent 61,452,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 556,000
3 remainder_Assets 2,748,000
4 LiabilitiesCurrent 14,006,000
5 LiabilitiesNoncurrent 1,666,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,595,802
9 ResearchAndDevelopmentExpense 21,764,544
10 remainder_Expenses 50,875,000
11 remainder_Revenues 10,041,810
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -16,730
  yvar yval
0 Assets 64,756,000
1 Liabilities 15,672,000
2 Expenses 94,235,346
3 Revenues 10,041,810
4 StockholdersEquity 49,084,000
5 NetIncome -84,193,536
6 ComprehensiveNetIncome -84,201,901
7 BaseVar 92,360,943
8 EconomicCapitalRatiobeforeLimitedLiability 0.567
9 EconomicCapitalRatio 1.94

Edgar->Model Mapping

Feature Distribution

Change over Time